Caprock Group LLC Buys 12,895 Shares of Gilead Sciences, Inc. $GILD

Caprock Group LLC increased its stake in Gilead Sciences, Inc. by 20.1% during the fourth quarter, purchasing an additional 12,895 shares, bringing their total holdings to 76,931 shares valued at $9.44 million. Other institutional investors also adjusted their positions in GILD, which currently holds a “Moderate Buy” consensus rating from analysts with an average price target of $157.35. The article also notes recent insider stock sales, upcoming earnings catalysts, and key financial metrics for Gilead Sciences.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin